Training in Signature Transdisciplinary Cardiovascular Sciences
标志性跨学科心血管科学培训
基本信息
- 批准号:10628014
- 负责人:
- 金额:$ 54.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
This is the first renewal for our T32 postdoctoral program (3-year duration, requesting to maintain our 6
positions/year) for MDs, DOs, PharmDs, and PhDs at the Medical College of Wisconsin’s Cardiovascular
Center. Building on our successes with 36% of appointees from underrepresented groups and 100% of
graduates (n=5) with further NIH funding (2 K99s, K01, F32, etc.), innovative new components include
diversification of leadership, a refined, more diverse group of faculty mentors, a new academic course, and
novel collaborations with campus centers to enhance translational science. With strong institutional support
and excellence in cardiovascular research, we leverage multi-PI leadership, the recent renewal of a Clinical
and Translational Science Award, a new American Heart Association Strategically Focused Research
Network award, and philanthropic support to fund trainee recruitment and enrich training. The Directors are
established physicians and scientists with extensive administrative experience who, along with 30 basic
scientists and translational investigators, serve as mentors. Our training program is scaffolded by a highly
integrated collaborative well-resourced research environment with a 360-degree evaluation system
surrounding our Signature Programs, specific areas of scientific excellence in 1) atherosclerosis,
thrombosis, and vascular biology, 2) cardiac biology and heart failure, 3) precision cardiovascular medicine,
and 4) hypertension. Our program emphasizes critical components designed to launch/sustain independent
research careers: 1) 3 years of support to enable grant (re)submissions, 2) individualized development plans
(IDP), 3) protected research time, 4) multidisciplinary mentoring teams, 5) training in core competencies ,
and 6) industry/biotechnology or scientific liaison career options for trainees not pursuing a traditional career
in academia. A rigorous nationwide selection process aids in our diverse trainee selection and team
mentoring is optimized using innovative tools (e.g., DiSC® and career path assessments). The IDP includes
foundational elements of progressive responsibility, coordination across multiple levels of translation,
interactions with cardiovascular and non-cardiovascular scientists, near-peer learning opportunities, specific
coursework, seminars, and conferences. Our long-term benchmark/goal is for more than 50% of our
postdoctoral trainees to transition into competitive faculty positions within 3 to 5 years of exiting our program.
Our intermediate benchmarks include publications, presentations, and grant submissio ns. Along with the
Directors, an Executive Committee and External Advisory Committee that have extensive experience with
career development, leadership, and directing training grants all provide program oversight and monitor
trainee progress every 6 and 12 months. Overall, the ultimate goal of our training program is to train the
next generation of cardiovascular scientists and physicians, including underrepresented groups in science
and medicine, by incorporating broad-based, personalized, supportive, and rigorous training opportunities.
项目摘要/摘要
这是我们T32博士后计划的第一个续订(持续3年,要求维护我们的6
威斯康星州医学院的MDS,DOS,PharmD和Phds的职位/年)
中心。以我们的成功为基础,占代表性不足的团体的约会和100%的约会
毕业生(n = 5),还有其他NIH资金(2 K99,K01,F32等),创新的新组件包括
领导力的多样化,一个精致,更多样化的教师导师,新的学术课程以及
与校园中心的新颖合作,以增强转化科学。有强烈的机构支持
和卓越的心血管研究,我们利用多PI领导力,最近的临床续约
和转化科学奖,这是一项新的美国心脏协会的战略性研究
网络奖和慈善支持,以资助受训者的招聘和丰富培训。董事是
拥有丰富行政经验的建立医师和科学家,以及30个基本
科学家和翻译研究人员,担任导师。我们的培训计划被高度脚手架
综合协作良好的研究环境,具有360度评估系统
围绕我们的签名计划,特定的科学卓越领域1)动脉粥样硬化,
血栓形成和血管生物学,2)心脏生物学和心力衰竭,3)精密心血管医学,
4)高血压。我们的计划强调了旨在启动/维持独立的关键组件
研究职业:1)3年支持授予赠款(RE)提交的支持,2)个性化的发展计划
(IDP),3)受保护的研究时间,4)多学科指导团队,5)核心能力培训,
6)不从事传统职业的学员的行业/生物技术或科学联络职业选择
在学术界。严格的国家选择过程有助于我们的潜水者训练者选择和团队
使用创新工具(例如Disc®和职业路径评估)优化指导。 IDP包括
渐进责任的基本要素,跨多个翻译的协调,
与心血管和非心血管科学家的互动,近点学习机会,特定的
课程,半小伙和会议。我们的长期基准/目标是超过50%
博士后学员将在退出计划后的3至5年内过渡到竞争性的教师职位。
我们的中级基准包括出版物,演讲和赠款。以及
董事,执行委员会和外部咨询委员会,在
职业发展,领导和指导培训赠款都提供计划监督和监控
学员每6和12个月进展一次。总体而言,我们培训计划的最终目标是培训
下一代的心血管科学家和医生,包括科学领域的代表性不足的群体
和医学,通过成立的广泛,个性化,支持和严格的培训机会。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sustained Use of the Impella 5.0 Heart Pump Enables Bridge to Clinical Decisions in 34 Patients.
持续使用 Impella 5.0 心脏泵为 34 名患者提供了临床决策的桥梁。
- DOI:10.14503/thij-20-7260
- 发表时间:2021
- 期刊:
- 影响因子:0.9
- 作者:Nelson,DanielW;Sundararajan,Sakthi;Klein,Evan;Joyce,LyleD;Durham,LucianA;Joyce,DavidL;Mohammed,AsimA
- 通讯作者:Mohammed,AsimA
Cardiac changes in collegiate athletes following SARS-CoV-2 infection and quarantine: a prospective Case-Control study.
- DOI:10.1080/07853890.2023.2269586
- 发表时间:2023
- 期刊:
- 影响因子:4.4
- 作者:
- 通讯作者:
Transgene-associated human growth hormone expression in pancreatic β-cells impairs identification of sex-based gene expression differences.
胰腺β细胞中转基因相关的人类生长激素表达损害了基于性别的基因表达差异的识别。
- DOI:10.1152/ajpendo.00229.2018
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Stancill,JenniferS;Osipovich,AnnaB;Cartailler,Jean-Philippe;Magnuson,MarkA
- 通讯作者:Magnuson,MarkA
Hypercholesterolemia Accelerates Both the Initiation and Progression of Angiotensin II-induced Abdominal Aortic Aneurysms.
高胆固醇血症加速血管紧张素 II 诱导的腹主动脉瘤的发生和进展。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Liu,Jing;Sawada,Hisashi;Howatt,DeborahA;Moorleghen,JessicaJ;Vsevolozhskaya,Olga;Daugherty,Alan;Lu,HongS
- 通讯作者:Lu,HongS
Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study.
血清生物标志物与接受初次细胞减灭术的卵巢癌患者术后并发症和辅助化疗开始延迟之间的关联:一项试点研究。
- DOI:10.1080/01635581.2022.2152060
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Ade,CarlJ;Dockery,Lauren;Walter,AdamC;Benbrook,DorisM;Vesely,SaraK;Hammond,StephenT;Moore,KathleenN;Holman,LauraL
- 通讯作者:Holman,LauraL
共 11 条
- 1
- 2
- 3
Ivor James Benjami...的其他基金
Advancing Student Potential for Inclusion with Research Experiences (ASPIRE)
通过研究经验提升学生融入的潜力(ASPIRE)
- 批准号:1067835610678356
- 财政年份:2023
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Training in Signature Transdisciplinary Cardiovascular Sciences
标志性跨学科心血管科学培训
- 批准号:1019899210198992
- 财政年份:2017
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Training in Signature Transdisciplinary Cardiovascular Sciences
标志性跨学科心血管科学培训
- 批准号:92095729209572
- 财政年份:2017
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Training in Signature Transdisciplinary Cardiovascular Sciences
标志性跨学科心血管科学培训
- 批准号:99141209914120
- 财政年份:2017
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Conditional HSF1 Expression for Ischemic Cardioprotection
条件性 HSF1 表达对缺血性心脏保护作用
- 批准号:76894217689421
- 财政年份:2009
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Conditional HSF1 Expression for Ischemic Cardioprotection
条件性 HSF1 表达对缺血性心脏保护作用
- 批准号:77861897786189
- 财政年份:2009
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Conditional HSF1 Expression for Ischemic Cardioprotection
条件性 HSF1 表达对缺血性心脏保护作用
- 批准号:81958858195885
- 财政年份:2009
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Protein Misfolding Diseases and Oxido-Reductive Pathways
蛋白质错误折叠疾病和氧化还原途径
- 批准号:79388197938819
- 财政年份:2009
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Protein Misfolding Diseases and Oxido-Reductive Pathways
蛋白质错误折叠疾病和氧化还原途径
- 批准号:81432678143267
- 财政年份:2009
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Protein Misfolding Diseases and Oxido-Reductive Pathways
蛋白质错误折叠疾病和氧化还原途径
- 批准号:85379698537969
- 财政年份:2009
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
相似国自然基金
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
游戏化mHealth干预模式下精神障碍出院患者自杀风险管理策略的实施科学研究——基于多阶段优化策略
- 批准号:72374095
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
基于成分转化-体内时空分布-空间代谢组学整体耦联阐释女贞子蒸制的科学内涵
- 批准号:82374041
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
虚拟实验环境下科学探究过程自动监测与适应性反馈研究
- 批准号:62377005
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于胆汁酸/CCL2/CCR2+TAMs代谢免疫穿越调控探讨乳腺癌“肝——乳”轴科学内涵与干预研究
- 批准号:82374446
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:1055763810557638
- 财政年份:2023
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
- 批准号:1037153710371537
- 财政年份:2023
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:1064487410644874
- 财政年份:2023
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
- 批准号:1072430410724304
- 财政年份:2023
- 资助金额:$ 54.22万$ 54.22万
- 项目类别:
Animal Models and Histology Core
动物模型和组织学核心
- 批准号:1071540410715404
- 财政年份:2023
- 资助金额:$ 54.22万$ 54.22万
- 项目类别: